Line 1: |
Line 1: |
− | test
| + | {{DISPLAYTITLE:Haematolymphoid Tumours 5th ed. (HAEM5) Table of Contents}} |
| + | |
| + | ==Myeloid proliferations and neoplasms== |
| + | |
| + | '''Myeloid precursor lesions''' |
| + | ''Clonal Haematopoiesis'' |
| + | - [[HAEM5:Clonal haematopoiesis]] |
| + | - [[HAEM5:Clonal cytopenias of undetermined significance]] |
| + | |
| + | '''Myeloproliferative neoplasms |
| + | ''Myeloproliferative neoplasms'' |
| + | - [[HAEM5:Chronic myeloid leukaemia]] |
| + | - [[HAEM5:Chronic neutrophilic leukaemia]] |
| + | - [[HAEM5:Chronic eosinophilic leukaemia]] |
| + | - [[HAEM5:Polycythaemia vera]] |
| + | - [[HAEM5:Essential thrombocythaemia]] |
| + | - [[HAEM5:Primary myelofibrosis]] |
| + | - [[HAEM5:Juvenile myelomonocytic leukaemia]] |
| + | - [[HAEM5:Myeloproliferative neoplasm, NOS]] |
| + | |
| + | '''Mastocytosis''' |
| + | - [[HAEM5:Cutaneous mastocytosis]] |
| + | - [[HAEM5:Systemic mastocytosis]] |
| + | - [[HAEM5:Mast cell sarcoma]] |
| + | |
| + | '''Myelodysplastic neoplasms''' |
| + | ''Myelodysplastic neoplasms, with defining genetic abnormalities'' |
| + | - [[HAEM5:Myelodysplastic neoplasm with low blasts and 5q deletion]] |
| + | - [[HAEM5:Myelodysplastic neoplasm with low blasts and SF3B1 mutation]] |
| + | - [[HAEM5:Myelodysplastic neoplasm with biallelic TP53 inactivation]] |
| + | ''Myelodysplastic neoplasms, morphologically defined'' |
| + | - [[HAEM5:Myelodysplastic neoplasm with low blasts]] |
| + | - [[HAEM5:Myelodysplastic neoplasm, hypoplastic]] |
| + | - [[HAEM5:Myelodysplastic neoplasm with increased blasts]] |
| + | ''Myelodysplastic neoplasms of childhood'' |
| + | - [[HAEM5:Childhood myelodysplastic neoplasm with low blasts]] |
| + | - [[HAEM5:Childhood myelodysplastic neoplasm with increased blasts]] |
| + | |
| + | '''Myelodysplastic/myeloproliferative neoplasms''' |
| + | - [[HAEM5:Chronic myelomonocytic leukaemia]] |
| + | - [[HAEM5:Myelodysplastic/myeloproliferative neoplasm with neutrophilia]] |
| + | - [[HAEM5:Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]] |
| + | - [[HAEM5:Myelodysplastic/myeloproliferative neoplasm, NOS]] |
| + | |
| + | '''Acute myeloid leukaemia''' |
| + | ''Acute myeloid leukaemia with defining genetic abnormalities'' |
| + | - [[HAEM5:Acute promyelocytic leukaemia with PML::RARA fusion]] |
| + | - [[HAEM5:Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion]] |
| + | - [[HAEM5:Acute myeloid leukaemia with CBFB::MYH11 fusion]] |
| + | - [[HAEM5:Acute myeloid leukaemia with DEK::NUP214 fusion]] |
| + | - [[HAEM5:Acute myeloid leukaemia with RBM15::MRTFA fusion]] |
| + | - [[HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion]] |
| + | - [[HAEM5:Acute myeloid leukaemia with KMT2A rearrangement]] |
| + | - [[HAEM5:Acute myeloid leukaemia with MECOM rearrangement]] |
| + | - [[HAEM5:Acute myeloid leukaemia with NUP98 rearrangement]] |
| + | - [[HAEM5:Acute myeloid leukaemia with NPM1 mutation]] |
| + | - [[HAEM5:Acute myeloid leukaemia with CEBPA mutation]] |
| + | - [[HAEM5:Acute myeloid leukaemia, myelodysplasia-related]] |
| + | - [[HAEM5:Acute myeloid leukaemia with other defined genetic alterations]] |
| + | ''Acute myeloid leukaemia, defined by differentiation'' |
| + | - [[HAEM5:Acute myeloid leukaemia with minimal differentiation]] |
| + | - [[HAEM5:Acute myeloid leukaemia without maturation]] |
| + | - [[HAEM5:Acute myeloid leukaemia with maturation]] |
| + | - [[HAEM5:Acute basophilic leukaemia]] |
| + | - [[HAEM5:Acute myelomonocytic leukaemia]] |
| + | - [[HAEM5:Acute monocytic leukaemia]] |
| + | - [[HAEM5:Acute erythroid leukaemia]] |
| + | - [[HAEM5:Acute megakaryoblastic leukaemia]] |
| + | ''Myeloid sarcoma'' |
| + | - [[HAEM5:Myeloid sarcoma]] |
| + | |
| + | '''Myeloid neoplasms, secondary''' |
| + | ''Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions'' |
| + | - [[HAEM5:Myeloid neoplasm post cytotoxic therapy]] |
| + | - [[HAEM5:Myeloid neoplasms associated with germline predisposition]] |
| + | - [[HAEM5:Myeloid proliferations associated with Down syndrome]] |
| + | |
| + | '''Myeloid/lymphoid neoplasms''' |
| + | ''Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement'' |
| + | - [[HAEM5:Myeloid/lymphoid neoplasm with PDGFRA rearrangement]] |
| + | - [[HAEM5:Myeloid/lymphoid neoplasm with PDGFRB rearrangement]] |
| + | - [[HAEM5:Myeloid/lymphoid neoplasm with FGFR1 rearrangement]] |
| + | - [[HAEM5:Myeloid/lymphoid neoplasm with JAK2 rearrangement]] |
| + | - [[HAEM5:Myeloid/lymphoid neoplasm with FLT3 rearrangement]] |
| + | - [[HAEM5:Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]] |
| + | - [[HAEM5:Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]] |
| + | |
| + | '''Acute leukaemias of mixed or ambiguous lineage''' |
| + | ''Acute leukaemia of ambiguous lineage with defining genetic abnormalities'' |
| + | - [[HAEM5:Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]] |
| + | - [[HAEM5:Mixed-phenotype acute leukaemia with KMT2A rearrangement]] |
| + | - [[HAEM5:Acute leukaemia of ambiguous lineage with other defined genetic alterations ]] |
| + | ''Acute leukaemia of ambiguous lineage, immunophenotypically defined'' |
| + | - [[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid]] |
| + | - [[HAEM5:Mixed-phenotype acute leukaemia, T/myeloid]] |
| + | - [[HAEM5:Mixed-phenotype acute leukaemia, rare types]] |
| + | - [[HAEM5:Acute leukaemia of ambiguous lineage, NOS]] |
| + | - [[HAEM5:Acute undifferentiated leukaemia]] |
| + | ==Histiocytic/Dendritic cell neoplasms== |
| + | |
| + | '''Plasmacytoid dendritic cell neoplasms''' |
| + | ''Plasmacytoid dendritic cell neoplasms'' |
| + | - [[HAEM5:Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] |
| + | - [[HAEM5:Blastic plasmacytoid dendritic cell neoplasm]] |
| + | |
| + | '''Langerhans cell and other dendritic cell neoplasms''' |
| + | ''Langerhans cells neoplasms'' |
| + | - [[HAEM5:Langerhans cell histiocytosis]] |
| + | - [[HAEM5:Langerhans cell sarcoma]] |
| + | ''Other dendritic cell neoplasms'' |
| + | - [[HAEM5:Indeterminate dendritic cell tumour]] |
| + | - [[HAEM5:Interdigitating dendritic cell sarcoma]] |
| + | |
| + | '''Histiocyte/macrophage neoplasms''' |
| + | ''Histiocytic neoplasms'' |
| + | - [[HAEM5:Juvenile xanthogranuloma]] |
| + | - [[HAEM5:Erdheim-Chester disease]] |
| + | - [[HAEM5:Rosai-Dorfman Disease]] |
| + | - [[HAEM5:ALK-positive histiocytosis]] |
| + | - [[HAEM5:Histiocytic sarcoma]] |
| + | ==B-cell lymphoid proliferations and lymphomas== |
| + | |
| + | '''Tumour like lesions with B-cell predominance''' |
| + | - [[HAEM5:Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] |
| + | - [[HAEM5:IgG4-related disease]] |
| + | - [[HAEM5:Unicentric Castleman disease]] |
| + | - [[HAEM5:Idiopathic multicentric Castleman disease]] |
| + | - [[HAEM5:KSHV/HHV8-associated multicentric Castleman disease]] |
| + | |
| + | '''Precursor B-cell neoplasms''' |
| + | ''B-lymphoblastic leukaemias/lymphomas'' |
| + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma]] |
| + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy]] |
| + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy]] |
| + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21]] |
| + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion]] |
| + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features]] |
| + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement]] |
| + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion]] |
| + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features]] |
| + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion]] |
| + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion ]] |
| + | - [[HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion]] |
| + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]] |
| + | - [[HAEM5:B-lymphoblastic leukaemia/lymphoma, NOS]] |
| + | |
| + | '''Mature B-cell neoplasms''' |
| + | ''Pre-neoplastic and neoplastic small lymphocytic proliferations '' |
| + | - [[HAEM5:Monoclonal B-cell lymphocytosis]] |
| + | - [[HAEM5:Chronic lymphocytic leukaemia/small lymphocytic lymphoma]] |
| + | ''Splenic B-cell lymphomas and leukaemias'' |
| + | - [[HAEM5:Hairy cell leukaemia]] |
| + | - [[HAEM5:Splenic marginal zone lymphoma]] |
| + | - [[HAEM5:Splenic diffuse red pulp small B-cell lymphoma]] |
| + | - [[HAEM5:Splenic B-cell lymphoma/leukaemia with prominent nucleoli]] |
| + | ''Lymphoplasmacytic lymphoma'' |
| + | - [[HAEM5:Lymphoplasmacytic lymphoma]] |
| + | ''Marginal zone lymphoma'' |
| + | - [[HAEM5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]] |
| + | - [[HAEM5:Primary cutaneous marginal zone lymphoma ]] |
| + | - [[HAEM5:Nodal marginal zone lymphoma]] |
| + | - [[HAEM5:Paediatric nodal marginal zone lymphoma]] |
| + | ''Follicular lymphoma'' |
| + | - [[HAEM5:In situ follicular B-cell neoplasm]] |
| + | - [[HAEM5:Follicular lymphoma]] |
| + | - [[HAEM5:Paediatric-type follicular lymphoma]] |
| + | - [[HAEM5:Duodenal-type follicular lymphoma]] |
| + | ''Cutaneous follicle centre lymphoma'' |
| + | - [[HAEM5:Primary cutaneous follicle centre lymphoma]] |
| + | ''Mantle cell lymphoma'' |
| + | - [[HAEM5:In situ mantle cell neoplasm]] |
| + | - [[HAEM5:Mantle cell lymphoma]] |
| + | - [[HAEM5:Leukaemic non-nodal mantle cell lymphoma]] |
| + | ''Transformations of indolent B-cell lymphomas'' |
| + | - [[HAEM5:Transformations of indolent B-cell lymphomas]] |
| + | ''Large B-cell lymphomas'' |
| + | - [[HAEM5:Diffuse large B-cell lymphoma, NOS]] |
| + | - [[HAEM5:T-cell/histiocyte-rich large B-cell lymphoma]] |
| + | - [[HAEM5:Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements]] |
| + | - [[HAEM5:ALK-positive large B-cell lymphoma]] |
| + | - [[HAEM5:Large B-cell lymphoma with IRF4 rearrangement]] |
| + | - [[HAEM5:High grade B-cell lymphoma with 11q aberrations]] |
| + | - [[HAEM5:Lymphomatoid granulomatosis]] |
| + | - [[HAEM5:EBV-positive diffuse large B-cell lymphoma]] |
| + | - [[HAEM5:Diffuse large B-cell lymphoma associated with chronic inflammation]] |
| + | - [[HAEM5:Fibrin-associated large B-cell lymphoma]] |
| + | - [[HAEM5:Fluid overload-associated large B-cell lymphoma]] |
| + | - [[HAEM5:Plasmablastic lymphoma]] |
| + | - [[HAEM5:Primary large B-cell lymphoma of immune-privileged sites]] |
| + | - [[HAEM5:Primary cutaneous diffuse large B-cell lymphoma, leg type]] |
| + | - [[HAEM5:Intravascular large B-cell lymphoma]] |
| + | - [[HAEM5:Primary mediastinal large B-cell lymphoma]] |
| + | - [[HAEM5:Mediastinal grey zone lymphoma]] |
| + | - [[HAEM5:High-grade B-cell lymphoma, NOS]] |
| + | ''Burkitt lymphoma'' |
| + | - [[HAEM5:Burkitt lymphoma]] |
| + | ''KSHV/HHV8-associated B-cell lymphoid proliferations and lymphomas'' |
| + | - [[HAEM5:Primary effusion lymphoma]] |
| + | - [[HAEM5:KSHV/HHV8-positive diffuse large B-cell lymphoma]] |
| + | - [[HAEM5:KSHV/HHV8-positive germinotropic lymphoproliferative disorder]] |
| + | ''Lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation'' |
| + | - [[HAEM5:Hyperplasias arising in immune deficiency/dysregulation]] |
| + | - [[HAEM5:Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation ]] |
| + | - [[HAEM5:EBV-positive mucocutaneous ulcer]] |
| + | - [[HAEM5:Lymphomas arising in immune deficiency / dysregulation ]] |
| + | - [[HAEM5:Inborn error of immunity-associated lymphoid proliferations and lymphomas]] |
| + | |
| + | '''Hodgkin lymphoma''' |
| + | - [[HAEM5:Classic Hodgkin lymphoma ]] |
| + | - [[HAEM5:Nodular lymphocyte predominant Hodgkin lymphoma]] |
| + | |
| + | '''Plasma cell neoplasms and other diseases with paraproteins''' |
| + | ''Monoclonal gammopathies'' |
| + | - [[HAEM5:Cold agglutinin disease ]] |
| + | - [[HAEM5:IgM monoclonal gammopathy of undetermined significance]] |
| + | - [[HAEM5:Non-IgM monoclonal gammopathy of undetermined significance]] |
| + | - [[HAEM5:Monoclonal gammopathy of renal significance]] |
| + | ''Diseases with monoclonal immunoglobulin deposition'' |
| + | - [[HAEM5:Immunoglobulin-related (AL) amyloidosis]] |
| + | - [[HAEM5:Monoclonal immunoglobulin deposition disease]] |
| + | ''Heavy chain diseases'' |
| + | - [[HAEM5:Mu heavy chain disease]] |
| + | - [[HAEM5:Gamma heavy chain disease]] |
| + | - [[HAEM5:Alpha heavy chain disease]] |
| + | ''Plasma cell neoplasms'' |
| + | - [[HAEM5:Plasmacytoma]] |
| + | - [[HAEM5:Plasma cell myeloma / multiple myeloma]] |
| + | - [[HAEM5:Plasma cell neoplasms with associated paraneoplastic syndrome]] |
| + | ==T-cell and NK-cell lymphoid proliferations and lymphomas== |
| + | |
| + | '''Tumour-like lesions with T-cell predominance''' |
| + | - [[HAEM5:Kikuchi-Fujimoto disease]] |
| + | - [[HAEM5:Autoimmune lymphoproliferative syndrome]] |
| + | - [[HAEM5:Indolent T-lymphoblastic proliferation]] |
| + | |
| + | '''Precursor T-cell neoplasms''' |
| + | ''T-lymphoblastic leukaemia / lymphoma'' |
| + | - [[HAEM5:T-lymphoblastic leukaemia / lymphoma, NOS]] |
| + | - [[HAEM5:Early T-precursor lymphoblastic leukaemia / lymphoma ]] |
| + | |
| + | '''Mature T-cell and NK-cell neoplasms''' |
| + | ''Mature T-cell and NK-cell leukaemias'' |
| + | - [[HAEM5:T-prolymphocytic leukaemia]] |
| + | - [[HAEM5:T-large granular lymphocytic leukaemia]] |
| + | - [[HAEM5:NK-large granular lymphocytic leukaemia]] |
| + | - [[HAEM5:Adult T-cell leukaemia/lymphoma]] |
| + | - [[HAEM5:Sezary syndrome]] |
| + | - [[HAEM5:Aggressive NK-cell leukaemia]] |
| + | ''Primary cutaneous T-cell lymphoid proliferations and lymphomas'' |
| + | - [[HAEM5:Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]] |
| + | - [[HAEM5:Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder]] |
| + | - [[HAEM5:Mycosis fungoides]] |
| + | - [[HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis]] |
| + | - [[HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma]] |
| + | - [[HAEM5:Subcutaneous panniculitis-like T-cell lymphoma]] |
| + | - [[HAEM5:Primary cutaneous gamma/delta T-cell lymphoma]] |
| + | - [[HAEM5:Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]] |
| + | - [[HAEM5:Primary cutaneous peripheral T-cell lymphoma, NOS]] |
| + | ''Intestinal T-cell and NK-cell lymphoid proliferations and lymphomas'' |
| + | - [[HAEM5:Indolent T-cell lymphoma of the gastrointestinal tract]] |
| + | - [[HAEM5:Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract]] |
| + | - [[HAEM5:Enteropathy-associated T-cell lymphoma]] |
| + | - [[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma]] |
| + | - [[HAEM5:Intestinal T-cell lymphoma, NOS]] |
| + | ''Hepatosplenic T-cell lymphoma'' |
| + | - [[HAEM5:Hepatosplenic T-cell lymphoma]] |
| + | ''Anaplastic large cell lymphoma'' |
| + | - [[HAEM5:ALK-positive anaplastic large cell lymphoma]] |
| + | - [[HAEM5:ALK-negative anaplastic large cell lymphoma]] |
| + | - [[HAEM5:Breast implant-associated anaplastic large cell lymphoma]] |
| + | ''Nodal T-follicular helper (TFH) cell lymphoma'' |
| + | - [[HAEM5:Nodal TFH cell lymphoma, angioimmunoblastic-type]] |
| + | - [[HAEM5:Nodal TFH cell lymphoma, follicular-type]] |
| + | - [[HAEM5:Nodal TFH cell lymphoma, NOS]] |
| + | ''Other peripheral T-cell lymphomas'' |
| + | - [[HAEM5:Peripheral T-cell lymphoma, NOS]] |
| + | ''EBV-positive NK-cell and T-cell lymphomas'' |
| + | - [[HAEM5:EBV-positive nodal T- and NK-cell lymphoma]] |
| + | - [[HAEM5:Extranodal NK/T-cell lymphoma]] |
| + | ''EBV-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood'' |
| + | - [[HAEM5:Severe mosquito bite allergy]] |
| + | - [[HAEM5:Hydroa vacciniforme lymphoproliferative disorder]] |
| + | - [[HAEM5:Systemic chronic active EBV disease]] |
| + | - [[HAEM5:Systemic EBV-positive T-cell lymphoma of childhood]] |
| + | ==Stroma-derived neoplasms of lymphoid tissues== |
| + | |
| + | '''Mesenchymal dendritic cell neoplasms''' |
| + | ''Follicular dendritic cell neoplasms'' |
| + | - [[HAEM5:Follicular dendritic cell sarcoma]] |
| + | - [[HAEM5:EBV-positive inflammatory follicular dendritic cell sarcoma]] |
| + | - [[HAEM5:Fibroblastic reticular cell tumour]] |
| + | |
| + | '''Myofibroblastic tumours''' |
| + | ''Myofibroblastic tumour'' |
| + | - [[HAEM5:Intranodal palisaded myofibroblastoma]] |
| + | |
| + | '''Spleen-specific vascular-stromal tumours''' |
| + | ''Splenic vascular-stromal tumours'' |
| + | - [[HAEM5:Littoral cell angioma]] |
| + | - [[HAEM5:Splenic hamartoma]] |
| + | - [[HAEM5:Sclerosing angiomatoid nodular transformation (SANT) of spleen]] |
| + | ==Genetic tumour syndromes== |
| + | - [[HAEM5:Fanconi anaemia]] |
| + | - [[HAEM5:Bloom syndrome]] |
| + | - [[HAEM5:Ataxia-telangiectasia syndrome]] |
| + | - [[HAEM5:RASopathies]] |